NG-nitro-L-arginine and its methyl ester inhibit brain synthesis of kynurenic acid possibly via nitric oxide-independent mechanism

Polish Journal of Pharmacology

Volumn 53, Issue 6, 2001, Pages 597-604

  Luchowski, Piotr ^a   Kocki, Tomasz ^a   Urbańskal, Ewa M ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Brain; In vitro; Kynurenic acid; Kynurenine aminotransferases; NG nitro L arginine; NG nitro L arginine methyl ester; Nitric oxide

Indexed keywords

7 NITROINDAZOLE; ARGININE; BRAIN ENZYME; GLUTAMATE RECEPTOR ANTAGONIST; KYNURENIC ACID; KYNURENINE AMINOTRANSFERASE; KYNURENINE AMINOTRANSFERASE 1; KYNURENINE AMINOTRANSFERASE 2; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN; BRAIN CORTEX; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME KINETICS; ENZYME SUBSTRATE; EXPERIMENTAL DESIGN; IN VITRO STUDY; INCUBATION TIME; MALE; NEUROTOXICITY; NONHUMAN; RAT; SEIZURE;

ANIMALS; ARGININE; CEREBRAL CORTEX; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; INDAZOLES; KINETICS; KYNURENIC ACID; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, WISTAR; SUBSTRATE SPECIFICITY; TRANSAMINASES;

EID: 0035689922     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazol and related substituted indazoles
2. Nitric oxide: A physiologic messenger molecule
3. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase
4. G-Nitro-L-arginine protects against ischemia-induced increases in nitric oxide and hippocampal neurodegeneration in the gerbil
5. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: Modulation by inhibition of nitric oxide synthesis
6. Nitric oxide in neurodegeneration
7. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
8. Nitric oxide does not mediate acute glutamate neurotoxicity, nor is neuroprotective, in rat brain slices
9. Characterization of rat brain kynurenine aminotransferases I and II
10. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis
11. Blockade of nitric oxide formation does not prevent glutamate-induced neurotoxicity in neuronal cultures from rat hippocampus
12. L-Nitro-arginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats
13. Excitotoxic models for neurodegenerative disorders
14. Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography
15. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
16. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection
17. Seizures induced by aminooxyacetic acid in mice: Pharmacological characteristics
18. Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine
19. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum
20. Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists
21. G-nitro-L-arginine of L-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons. Prolonged application enhances neuroprotective efficacy
22. G-nitro-L-arginine enhances neuronal death following transient forebrain ischemia in gerbils
23. G-nitro-L-arginine methyl ester in plasma by high-performance liquid chromatography